<p>A molecule for use in a method of treatment or diagnosis of Kawasaki Disease in an individual, the molecule comprising: (a) CACNA2D3; (b) CAMK2D; (c) KCNIP4; (d) ANGPT1; (e) NAALADL2; (f) ZFHX3; (g) MPHOSPH10; (h) a sequence having at least 90% sequence identity to any of (a) to (g); or (i) a modulator of any of (a) to (e). We also describe the use of Pregabalin ((3S)-3-(aminomethyl)-5-methyl-hexanoic acid) in the treatment or prevention of Kawasaki Disease in an individual.</p>
申请公布号
EP2116618(A1)
申请公布日期
2009.11.11
申请号
EP20090251278
申请日期
2009.05.08
申请人
AGENCY FOR SCIENCE, TECHNOLOGY AND RESEARCH;EMMA CHILDREN'S HOSPITAL;THE UNIVERSITY OF WESTERN AUSTRALIA
发明人
KUIJPERS, TACO;HIBBERD, MARTIN LLOYD;BURGNER, DAVID PAUL;DOMINGUEZ, SONIA MARIA DAVILA